Mistletoe in oncological treatment: a systematic review

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Perception of risk and communication among conventional and complementary health care providers involving cancer patients’ use of complementary therapies: a literature review

(2016) Trine Stub et al.   BMC Complementary and Alternative Medicine

A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients

(2014) Alessandra Longhi et al.   Evidence-based Complementary and Alternative Medicine

Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial

(2014) Wilfried Tröger et al.   Evidence-based Complementary and Alternative Medicine

Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival

(2013) W. Tröger et al.   EUROPEAN JOURNAL OF CANCER

P02.116. The relationship between deqi and the effect of acupuncture

(2012) Y Choi et al.   BMC Complementary and Alternative Medicine

Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract(Iscador): A Meta-Analysis

(2011) Arndt Büssing et al.   Evidence-based Complementary and Alternative Medicine

How Many Cancer Patients Use Complementary and Alternative Medicine

(2011) Markus Horneber et al.   INTEGRATIVE CANCER THERAPIES

Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies

(2010) Gunver S. Kienle et al.   INTEGRATIVE CANCER THERAPIES

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research

(2009) Gunver S Kienle et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients

(2009) Alessandra Longhi et al.   European Journal of Integrative Medicine